Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes

Reactive gliosis caused by post‐traumatic injury often results in marked expression of chondroitin sulfate proteoglycan (CSPG), which inhibits neurite outgrowth and regeneration. Methylprednisolone (MP), a synthetic glucocorticoid, has been shown to have neuroprotective and anti‐inflammatory effects for the treatment of acute spinal cord injury (SCI). However, the effect of MP on CSPG expression in reactive glial cells remains unclear. In our study, we induced astrocyte reactivation using α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionate (AMPA) and cyclothiazide to mimic the excitotoxic stimuli of SCI. The expression of glial fibrillary acidic protein (GFAP), a marker of astrocyte reactivation, and CSPG neurocan and phosphacan were significantly elevated by AMPA treatment. The conditioned media from AMPA‐treated astrocytes strongly inhibited neurite outgrowth of rat dorsal root ganglion neurons, and this effect was reversed by pretreatment with MP. Furthermore, MP downregulated GFAP and CSPG expression in adult rats with SCI. Additionally, both the glucocorticoid receptor (GR) antagonist RU486 and GR siRNA reversed the inhibitory effects of MP on GFAP and neurocan expression. Taken together, these results suggest that MP may improve neuronal repair and promote neurite outgrowth after excitotoxic insult via GR‐mediated downregulation of astrocyte reactivation and inhibition of CSPG expression. © 2008 Wiley‐Liss, Inc.

[1]  S. McMahon,et al.  Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury , 2006, The Journal of Neuroscience.

[2]  A. Akaike,et al.  Pregnenolone sulphate attenuates AMPA cytotoxicity on rat cortical neurons , 2005, The European journal of neuroscience.

[3]  J. Cidlowski,et al.  Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.

[4]  Maiken Nedergaard,et al.  New roles for astrocytes (stars at last) , 2003, Trends in Neurosciences.

[5]  D. Snow,et al.  Neurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation , 2003, Experimental Neurology.

[6]  M. Tuszynski,et al.  The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.

[7]  Wutian Wu,et al.  Axonal regeneration of Clarke’s neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC , 2003, Experimental Neurology.

[8]  O N Hausmann,et al.  Post-traumatic inflammation following spinal cord injury , 2003, Spinal Cord.

[9]  Robert Schweitzer,et al.  Glucocorticoid receptor antagonism by cyproterone acetate and RU486. , 2003, Molecular pharmacology.

[10]  Sylvan S Shank,et al.  Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius. , 2003, American journal of physiology. Heart and circulatory physiology.

[11]  C. Feuerstein,et al.  Chondroitin and keratan sulfates have opposing effects on attachment and outgrowth of ventral mesencephalic explants in culture , 2002, Journal of neuroscience research.

[12]  James W. Fawcett,et al.  Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.

[13]  J. Fawcett,et al.  Chondroitin sulphate proteoglycans in the CNS injury response. , 2002, Progress in brain research.

[14]  R. Gold,et al.  Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation1 , 2001, The Journal of Immunology.

[15]  Gyeong-Moon Kim,et al.  Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.

[16]  J. Fawcett,et al.  Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes , 2000, The Journal of Neuroscience.

[17]  M. Jurynec,et al.  The Chondroitin Sulfate Proteoglycans Neurocan and Phosphacan Are Expressed by Reactive Astrocytes in the Chronic CNS Glial Scar , 1999, The Journal of Neuroscience.

[18]  C. Haas,et al.  Entorhinal Cortex Lesion in Adult Rats Induces the Expression of the Neuronal Chondroitin Sulfate Proteoglycan Neurocan in Reactive Astrocytes , 1999, The Journal of Neuroscience.

[19]  Douglas K. Anderson,et al.  Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation , 1999, Experimental Neurology.

[20]  V. Perry,et al.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord , 1999, The European journal of neuroscience.

[21]  V. Perry,et al.  Cytokine-induced acute inflammation in the brain and spinal cord. , 1999, Journal of neuropathology and experimental neurology.

[22]  E. Powell,et al.  Dissection of astrocyte‐mediated cues in neuronal guidance and process extension , 1999, Glia.

[23]  J. Xu,et al.  Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. , 1998, Brain research. Molecular brain research.

[24]  Jerry Silver,et al.  Activated Macrophages and the Blood–Brain Barrier: Inflammation after CNS Injury Leads to Increases in Putative Inhibitory Molecules , 1997, Experimental Neurology.

[25]  J. Silver,et al.  Glial cell extracellular matrix: boundaries for axon growth in development and regeneration , 1997, Cell and Tissue Research.

[26]  A. Cato,et al.  Molecular mechanisms of anti‐inflammatory action of glucocorticoids , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  Kahori Yamada,et al.  AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  C. Finch,et al.  Transcriptional regulation of glial fibrillary acidic protein by corticosterone in rat astrocytes in vitro is influenced by the duration of time in culture and by astrocyte-neuron interactions. , 1995, Endocrinology.

[29]  M. Schwab,et al.  Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat , 1995, Brain Research.

[30]  M. Norenberg,et al.  Astrocyte Responses to CNS Injury , 1994, Journal of neuropathology and experimental neurology.

[31]  V Balasingam,et al.  Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  W. Young,et al.  The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. , 1994, Journal of neurosurgery.

[33]  J. Silver,et al.  β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth , 1993, Experimental Neurology.

[34]  A. Caplan,et al.  Structural domains in chondroitin sulfate identified by anti-chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. , 1993, Matrix.

[35]  F. Besnard,et al.  Analysis of a Segment of the Human Glial Fibrillary Acidic Protein Gene That Directs Astrocyte‐Specific Transcription , 1993, Journal of neurochemistry.

[36]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[37]  L. Hösli,et al.  Receptors for neurotransmitters on astrocytes in the mammalian central nervous system , 1993, Progress in Neurobiology.

[38]  M. Sparkes.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data , 1992 .

[39]  M. Bracken,et al.  The Second National Acute Spinal Cord Injury Study. , 1990, Journal of neurotrauma.

[40]  W. Collins,et al.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. , 1992, Journal of neurosurgery.

[41]  J. Silver,et al.  Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  K. McCarthy,et al.  Astroglia in culture , 1991 .

[43]  M. Bracken,et al.  Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. , 1991, Journal of neurotrauma.

[44]  J. Sarid.  Identification of a cis‐acting positive regulatory element of glial fibrillary acidic protein gene , 1991, Journal of neuroscience research.

[45]  M. Karin,et al.  Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.

[46]  Stephan Gebel,et al.  Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.

[47]  M. Bracken.  Methylprednisolone in the management of acute spinal cord injuries , 1990, The Medical journal of Australia.

[48]  J. Silver,et al.  Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro , 1990, Experimental Neurology.

[49]  C. Hsu,et al.  Methylprednisolone in spinal cord injury: the possible mechanism of action. , 1990, Journal of neurotrauma.

[50]  D. Choi,et al.  Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay , 1987, Journal of Neuroscience Methods.

[51]  E. Hall,et al.  Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. , 1985, Central nervous system trauma : journal of the American Paralysis Association.

[52]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[53]  E. Hall,et al.  Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue , 1981, Experimental Neurology.

[54]  A. Bignami,et al.  Immunogenic properties of the glial fibrillary acidic protein , 1976, Brain Research.

[55]  A. Bignami,et al.  Heterogeneity of the glial fibrillary acidic protein in gliosed human brains. , 1974, Journal of the neurological sciences.

[56]  A. Bignami,et al.  Astrocyte‐specific protein and neuroglial differentiation. An immunofluorescence study with antibodies to the glial fibrillary acidic protein , 1974, The Journal of comparative neurology.

[57]  L. Eng,et al.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. , 1972, Brain research.